溴吡斯的明治疗重症肌无力的临床问题分析

Adverse Reactions and Clinical Issues of Pyridostigmine Bromide in Treatment of Myasthenia Gravis

溴吡斯的明是治疗重症肌无力(MG)的一线药物,但临床上并非所有亚型MG均能获得良好的治疗效果,尤其是在幼儿、青少年、孕妇等特殊群体中的安全性和有效性有待探讨。本文就溴吡斯的明治疗MG的不良反应和目前存在的临床问题进行阐述,并提出可能的解决措施,以期为后续完善MG治疗方案提供借鉴。

Pyridostigmine bromide is a first-line drug for the treatment of myasthenia gravis(MG).In clinical application,its therapeutic effects are not good on all subtypes of MG,especially in the treatment of special groups for which no norms can yet be found.This article elaborates on the adverse reactions and current clinical problems of pyridostigmine bromide in the treatment of MG,and proposes possible solutions to provide reference for improving MG treatment plans in the future.